You can Subscribe to our RSS FEED: which delivers brain tumor news and additions to the website via RSS.
Click HERE for details on RSS.
Displaying items 526 to 550 of about 5880
Next 25
03/15/2022
Hoops For Hannah, Brain Tumor Fundraiser
03/02/2022
Overlook Medical Center chosen as SURVIVE trial site, enrolling patients for new brain tumor vaccine
02/28/2022
Genome-Wide Expression and Anti-Proliferative Effects of Electric Field Therapy on Pediatric and Adult Brain Tumors
02/25/2022
Tumour treating fields in glioblastoma: is the treatment tolerable, effective, and practical in UK patients?
New Data Finds Tumor Treating Fields Initiates Downstream Anti-Tumor Response
Plus Therapeutics Partners with Medidata to Apply Innovative Synthetic Control Arm? Solution to Accelerate Brain Cancer Clinical Trial
GT Medical Technologies Announces 2021 GammaTile® Therapy ELITE Member Roster for Use of Its Innovative Brain Tumor Treatment
02/23/2022
Creating a Precision Oncology Platform Trial for Brain Cancer
02/20/2022
Convection enhanced delivery of the oncolytic adenovirus Delta24-RGD in recurrent GBM patients; a phase I clinical trial including correlative studies
02/13/2022
Socioeconomic factors affecting survivorship of glioblastoma patients in the Philippines
02/11/2022
Teenager with brain tumour flies home after failed US cancer trial leaves family with £370,000 bill
02/10/2022
‘Decision switch’ Discovered in Mutations Linked to Common Brain Tumor
02/09/2022
Musella Foundation awards $50,000 brain tumor research grant!
"Rare Enough" One man`s story about his battle with a Glioblastoma
02/06/2022
Promising Treatment for Deadly Brain Cancer
The Impact of Tumor Treating Fields on Glioblastoma Progression Patterns
01/29/2022
GammaTile® brachytherapy in the treatment of recurrent glioblastomas
01/28/2022
Are cancer patients better off if they participate in clinical trials? A mixed methods study
01/24/2022
Mark Cuban Cost Plus Drug Company`s Online Pharmacy Launches with Lowest Prices on 100 Lifesaving Prescriptions
01/22/2022
Results of a post hoc analysis of the EF-14 study showed Optune + TMZ was associated with increased median OS vs TMZ alone in patients ineligible for surgical resection
01/20/2022
Prolonged response of recurrent IDH-wild-type glioblastoma to laser interstitial thermal therapy with pembrolizumab
Vigeo Therapeutics Advances VT1021 Into Phase 2-3 Registrational Study for Glioblastoma
01/13/2022
Systemic high-dose dexamethasone treatment may modulate the efficacy of intratumoral viral oncolytic immunotherapy in glioblastoma models
01/07/2022
Adult H3K27M mutated thalamic glioma patients display a better prognosis than unmutated patients